aTyr Pharma, Inc.

aTyr Pharma, Inc. financial statements

aTyr Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 190K10-K
Net income−USD 74.12M10-K
Cash and equivalentsUSD 10.74M10-Q
Total debtUSD 12.03MEODHD

aTyr Pharma, Inc. financials on 6ix · aTyr Pharma, Inc. on 6ix